NextFerm Technologies Ltd (TLV:NXFR.M)
10,490
-20 (-0.19%)
At close: Feb 18, 2026
NextFerm Technologies Revenue
NextFerm Technologies had revenue of $147.00K USD in the half year ending June 30, 2025, a decrease of -40.49%. This brings the company's revenue in the last twelve months to $247.00K, up 124.55% year-over-year. In the year 2024, NextFerm Technologies had annual revenue of $174.00K, down -38.52%.
Revenue (ttm)
$247.00K
Revenue Growth
+124.55%
P/S Ratio
19.44
Revenue / Employee
$22.45K
Employees
11
Market Cap
16.18M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 174.00K | -109.00K | -38.52% |
| Dec 31, 2023 | 283.00K | 21.00K | 8.02% |
| Dec 31, 2022 | 262.00K | 20.00K | 8.26% |
| Dec 31, 2021 | 242.00K | 147.00K | 154.74% |
| Dec 31, 2020 | 95.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pomvom | 229.08M |
| Airtouch Solar | 44.24M |
| Upsellon Brands Holdings | 42.60M |
| Tikun Olam-Cannbit Pharmaceuticals | 34.95M |
| Tigi Ltd. | 9.53M |
| Shamaym Improve | 3.15M |
| Can-Fite BioPharma | 1.89M |
| Big Tech 50 R&D-Limited Partnership | -7.01M |